Rubius Therapeutics, Inc. (RUBY) Social Stream
RUBIUS THERAPEUTICS INC (RUBY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RUBY.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 5 | $40 | $14 | $28 | $0.083 | 33634.94% |
| 2021-11-17 | 5 | $40 | $14 | $27.4 | $0.083 | 32912.05% |
| 2021-12-22 | 5 | $40 | $14 | $24.4 | $0.083 | 29297.59% |
| 2022-01-31 | 5 | $40 | $14 | $23 | $0.083 | 27610.84% |
| 2022-02-09 | 5 | $40 | $14 | $20.6 | $0.083 | 24719.28% |
| 2022-02-28 | 5 | $40 | $5 | $19 | $0.083 | 22791.57% |
| 2022-04-11 | 2 | $5 | $5 | $5 | $0.083 | 5924.1% |
| 2022-04-12 | 5 | $20 | $3 | $11.6 | $0.083 | 13875.9% |
| 2022-04-13 | 5 | $20 | $3 | $8.666 | $0.083 | 10340.96% |
| 2022-05-11 | 5 | $20 | $2 | $8.166 | $0.083 | 9738.55% |
| 2022-08-09 | 5 | $20 | $1 | $7.2 | $0.083 | 8574.7% |
| 2022-09-09 | 4 | $20 | $1.5 | $8.833 | $0.083 | 10542.17% |
The Trend in the Analyst Price Target
RUBY's average price target has moved down $10.17 over the prior 28 weeks.
RUBY reports an average of 494.35% for its upside potential over the past 151 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-11 | 1 | 20 | 3.0 | 13.600 | 2.41 | 464.32% |
| 2022-04-13 | 5 | 20 | 3.0 | 8.666 | 2.14 | 304.95% |
| 2022-05-11 | 5 | 20 | 2.0 | 8.166 | 1.28 | 537.97% |
| 2022-09-09 | 4 | 20 | 1.0 | 6.875 | 1.12 | 513.84% |
| 2022-09-09 | 4 | 20 | 1.5 | 8.833 | 1.12 | 688.66% |
RUBY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.6 | 1 | 0 | 4 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
RUBY's average broker recommendation rating worsened by 0.8 over the prior 123 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, RUBIUS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 2198.6% of them.
- In the context of stocks in the mid market cap category, RUBIUS THERAPEUTICS INC's variance in analysts' estimates is lower than -1792.73% of them.
- In the context of stocks in the mid market cap category, RUBIUS THERAPEUTICS INC's average analyst price target is higher than 379.79% of them.
- In the context of stocks in the mid market cap category, RUBIUS THERAPEUTICS INC's number of analysts covering the stock is higher than 409.8% of them.
In the Pharmaceutical Products industry, KRYS, MESO, and PLX are the three stocks most similar to RUBIUS THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is RUBY a Buy, Hold or Sell? See the POWR Ratings now!